CBI Biomedical Innovation Drug Safety Symposium

CBI Biomedical Innovation Drug Safety Symposium

MIT Center for Biomedical Innovation Joins the Engineering Systems Division

The Center for Biomedical Innovation (CBI) has joined the MIT Engineering Systems Division (ESD), allowing the two to more closely align their efforts in tackling large-scale challenges in the healthcare industry.

"Working within ESD will give CBI the opportunity to leverage the combination of ESD's world-class expertise in engineering systems with CBI's deep knowledge of, and experience in, the healthcare industry," said Claude Canizares, chair of CBI's Strategy & Policy Council.

Full Release

Welcome

CBI's mission is to improve global health by overcoming obstacles to the development and implementation of biomedical innovation.

CBI provides a safe haven for collaborative research among industry, academia, and government, and draws on the expertise of MIT’s schools of engineering, science, and management, as well as the Harvard-MIT Division of Health Sciences and Technology (HST)

The Role of CBI at MIT:

  • Identify and frame actionable unmet needs.
  • Identify and engage the right faculty & students to address the needs.
  • Build & maintain theme-based communities of stakeholders (industry, government, and academia) to optimize translation of research output into public health value.

Events

Feb. 3
Biomanufacturing Workshop
Feb. 17
Drug Safety Workshop
March 10 & 11
Future of Biomanufacturing Conference
(Co-Sponsored by MIT Industrial Liaison Program)
November 5 & 6 to be confirmed
4th Annual Stakeholders' Summit

Research

The CBI is focused on optimizing biomedical innovation through collaborative effort in several research areas, including: Safety Assessment; Manufacturing and Distribution Systems;Economic, Financial & Regulatory Risk Management; and R&D Redesign